The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s pericarditis market report forecasts the pericarditis market size to grow to $2.85 Billion by 2027, with a CAGR (compound annual growth rate) of almost 7%.

Learn More On The Pericarditis Market Report 2023 – https://www.thebusinessresearchcompany.com/report/pericarditis-global-market-report

Pericarditis Market Size Forecast
The global pericarditis market is expected to grow from $2.03 billion in 2022 to $2.18 billion in 2023 at a compound annual growth rate (CAGR) of 7.58%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global pericarditis market size is expected to reach $2.85 billion in 2027 at a CAGR of 6.99%.

North America held the largest pericarditis market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Pericarditis Market Driver ­– Increase In The Prevalence Of Cardiovascular Diseases
According to an article provided by the Centres for Disease Control and Prevention, a US-based national public health body, every 40 seconds in October 2022, a heart attack happens in the United States. Every year, over 805,000 Americans have a heart attack. One in every five heart attacks is silent; the person is unaware of the extent of the damage. Tobacco use, high blood pressure, and high cholesterol are all significant risk factors for heart disease. As a result, the rising prevalence of cardiovascular disorders is propelling the pericarditis devices market forward.

Request for A Sample Of The Global Pericarditis Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9170&type=smp

Key Pericarditis Market Trend – Product Innovation
To increase their market position, major pericarditis enterprises are focusing on producing new revolutionary products. CMR Surgical, a UK-based medical device business that produces surgical robotics, for example, will unveil the ‘Versius® Surgical Robotic System’ 3D HD vision fully-wristed technology-based equipment for pericardiectomy in October 2020. The product is unusual in that it includes an ergonomic console that allows doctors to sit or stand during surgery and perform more limited access surgery, allowing more patients to get better surgical treatment. Versius is a human-like bionic arm with a modular design that allows the surgeon to employ only the number of arms required for the treatment.

Pericarditis Market Segment
1) By Type: Acute Pericarditis, Chronic Pericarditis, Recurrent Pericarditis
2) By Diagnosis And Treatment: Electrocardiogram (ECG), Echocardiogram, Computerized Tomography (Ct), X-Ray, Medication, Surgical Treatment
3) By Application: Hospitals And Clinics, Medical Institutes, Ambulatory Surgical Centers, Research Organizations

Pericarditis Market Major Players and Strategies
Major players in the pericarditis market are Pfizer Inc., AstraZeneca PLC, Allergan PLC, Merck & Co., Inc., Bayer AG, Reckitt Benckiser Group PLC, PerkinElmer, Inc., FUJIFILM Holdings Corporation, Novartis International AG, Sanofi S.A., Johnson & Johnson Services, Inc., Takeda Pharmaceutical Co. Ltd., Zydus Cadila Healthcare Ltd., Sun Pharmaceutical Ltd. and Regeneron Pharmaceuticals Inc.

Arena Pharmaceuticals was acquired for USD 6.7 million by Pfizer Inc., a US-based pharmaceutical and biotechnology business, in March 2022. Pfizer will be able to enhance its portfolio with diverse and development-stage pharmaceutical prospects in the inflammation and immunology therapeutic domains as a result of this purchase. This acquisition will allow Pfizer to make breakthroughs in immuno-inflammatory illnesses and accelerate clinical development. Arena Pharmaceuticals is a biopharmaceutical business established in the United States that is developing novel potential medicines. Arena is developing a class of anti-inflammatory drugs, one of which is currently undergoing rigorous testing for a variety of illnesses.

The Pericarditis Global Market Report 2023 covers regional data on pericarditis market size, pericarditis market trends and drivers, opportunities, strategies, and pericarditis market competitor analysis. The countries covered in the pericarditis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Pericarditis is an inflammation and irritation of the pericardium, a thin sac-like tissue that surrounds the heart. The most common symptom is chest pain, which is produced by inflamed sac layers pushing against the heart.

View More Reports Related To The Pericarditis Market –
Market Research Services Global Market Report 2023
Marketing Automation Global Market Report 2023
Marketing Research And Analysis Services Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: